Stat5 Synergizes with T Cell Receptor/Antigen Stimulation in the Development of Lymphoblastic Lymphoma
Open Access
- 30 June 2003
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 198 (1), 79-89
- https://doi.org/10.1084/jem.20021548
Abstract
Signal transducer and activator of transcription (STAT) proteins are latent transcription factors that mediate a wide range of actions induced by cytokines, interferons, and growth factors. We now report the development of thymic T cell lymphoblastic lymphomas in transgenic mice in which Stat5a or Stat5b is overexpressed within the lymphoid compartment. The rate of lymphoma induction was markedly enhanced by immunization or by the introduction of TCR transgenes. Remarkably, the Stat5 transgene potently induced development of CD8+ T cells, even in mice expressing a class II–restricted TCR transgene, with resulting CD8+ T cell lymphomas. These data demonstrate the oncogenic potential of dysregulated expression of a STAT protein that is not constitutively activated, and that TCR stimulation can contribute to this process.Keywords
This publication has 43 references indexed in Scilit:
- Bethesda proposals for classification of lymphoid neoplasms in miceBlood, 2002
- STAT proteins: novel molecular targets for cancer drug discoveryOncogene, 2000
- How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 geneThe EMBO Journal, 2000
- STATs in oncogenesisOncogene, 2000
- The role of Stat5a and Stat5b in signaling by IL-2 family cytokinesOncogene, 2000
- Fetal Anemia and Apoptosis of Red Cell Progenitors in Stat5a−/−5b−/− MiceCell, 1999
- JAKS AND STATS: Biological ImplicationsAnnual Review of Immunology, 1998
- Jak-STAT Signaling Induced by the v- abl oncogeneScience, 1995
- Characterization of a protein tyrosine phosphatase (RIP) expressed at a very early stage of differentiation in both mouse erythroleukemia and embryonal carcinoma cellsFEBS Letters, 1995
- The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.The Journal of Experimental Medicine, 1992